Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.03 USD | -25.00% | -.--% | -95.72% |
May. 08 | Motion for Asset Sale Approved for DMK Pharmaceuticals Corporation | CI |
Apr. 11 | North American Morning Briefing : Stock Futures Edge Lower Ahead of PPI Inflation Gauge | DJ |
Financials (USD)
Sales 2021 | 2.21M | Sales 2022 | 4.76M | Capitalization | 25.39M |
---|---|---|---|---|---|
Net income 2021 | -45M | Net income 2022 | -26M | EV / Sales 2021 | 31.5 x |
Net cash position 2021 | 20.53M | Net cash position 2022 | 433K | EV / Sales 2022 | 5.25 x |
P/E ratio 2021 |
-1.9
x | P/E ratio 2022 |
-0.96
x | Employees | 12 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 90.68% |
Latest transcript on DMK Pharmaceuticals Corporation
1 day | -25.00% | ||
1 month | -9.91% | ||
3 months | -62.50% | ||
6 months | -94.72% | ||
Current year | -95.72% |
Managers | Title | Age | Since |
---|---|---|---|
Ebrahim Versi
CEO | Chief Executive Officer | 71 | 23-05-24 |
Seth Cohen
DFI | Director of Finance/CFO | 42 | 23-10-15 |
Robert H. Uhl
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Howard Birndorf
BRD | Director/Board Member | 74 | 19-08-25 |
Ebrahim Versi
CEO | Chief Executive Officer | 71 | 23-05-24 |
Vickie Reed
BRD | Director/Board Member | 62 | 22-05-23 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 0.03 | -25.00% | 2,713 |
24-05-30 | 0.04 | +33.33% | 15,670 |
24-05-29 | 0.03 | -.--% | 3,190 |
24-05-28 | 0.03 | -.--% | 27,906 |
24-05-24 | 0.03 | -.--% | 34,844 |
Delayed Quote OTC Markets, May 31, 2024 at 03:55 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-95.72% | 303K | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
+9.78% | 210B | |
-5.52% | 206B | |
+6.17% | 164B |
- Stock Market
- Equities
- DMKPQ Stock